找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Interferon and Cancer; Karol Sikora Book 1983 Plenum Press, New York 1983 brain tumors.cell.clinical trial.hormones.interferon.leukemia.ly

[復(fù)制鏈接]
查看: 30216|回復(fù): 57
樓主
發(fā)表于 2025-3-21 20:00:09 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Interferon and Cancer
編輯Karol Sikora
視頻videohttp://file.papertrans.cn/471/470998/470998.mp4
圖書封面Titlebook: Interferon and Cancer;  Karol Sikora Book 1983 Plenum Press, New York 1983 brain tumors.cell.clinical trial.hormones.interferon.leukemia.ly
描述Interferon was first discovered in 1957. Over the last five years it has become almost a household word. Many believe it to be a drug with already proven efficacy against cancer and viral infection. The media has distorted any cool scientific view of the data available. We have learned much about the complexity of the interferon system. We know some of the switches involved in interferon gene expression and its secretion by virally and immune stimulated cells. We also know that it binds to a cell surface receptor, mediating its complex effects on target cells by a series of second messengers. The advent of the new techniques of modern molecular biology, such as monoclonal antibodies and gene cloning, has had tremendous impact on the rate of acquisition of knowledge. Such techniques have provided us with almost unlimited quantities of highly purified interferon for clinical trial in patients with a spectrum of infectious and malignant diseases. The information we have gathered raises many more questions. Why should there be several families of interferon genes? What is their true physiolo- gical role? How are they interrelated functionally? Interferon is clearly a cellular hormone p
出版日期Book 1983
關(guān)鍵詞brain tumors; cell; clinical trial; hormones; interferon; leukemia; lymphoma; molecular biology
版次1
doihttps://doi.org/10.1007/978-1-4684-1170-6
isbn_softcover978-1-4684-1172-0
isbn_ebook978-1-4684-1170-6
copyrightPlenum Press, New York 1983
The information of publication is updating

書目名稱Interferon and Cancer影響因子(影響力)




書目名稱Interferon and Cancer影響因子(影響力)學(xué)科排名




書目名稱Interferon and Cancer網(wǎng)絡(luò)公開度




書目名稱Interferon and Cancer網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Interferon and Cancer被引頻次




書目名稱Interferon and Cancer被引頻次學(xué)科排名




書目名稱Interferon and Cancer年度引用




書目名稱Interferon and Cancer年度引用學(xué)科排名




書目名稱Interferon and Cancer讀者反饋




書目名稱Interferon and Cancer讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 20:56:28 | 只看該作者
Annapurna Vyakarnamlickartig dargestellt. Schlie?lich wird ein Therapieleitfaden zur Behandlung verschiedenster dissoziativer Symptome und St?rungen beschrieben. .Der modulare Aufbau des Leitfadens erlaubt es, das spezifische Vor978-3-642-35066-5
板凳
發(fā)表于 2025-3-22 03:55:13 | 只看該作者
地板
發(fā)表于 2025-3-22 05:16:04 | 只看該作者
5#
發(fā)表于 2025-3-22 08:58:26 | 只看該作者
tically discusses ongoing and transforming power structures of heritage and memory in today’s Europe. The book combines theoretical and methodological contributions to the debates on European heritage and memory studies and in-depth analyses of empirical case studies. Its main aim is to bring resear
6#
發(fā)表于 2025-3-22 15:55:49 | 只看該作者
Karol Sikoratically discusses ongoing and transforming power structures of heritage and memory in today’s Europe. The book combines theoretical and methodological contributions to the debates on European heritage and memory studies and in-depth analyses of empirical case studies. Its main aim is to bring resear
7#
發(fā)表于 2025-3-22 19:47:30 | 只看該作者
8#
發(fā)表于 2025-3-22 22:25:37 | 只看該作者
9#
發(fā)表于 2025-3-23 01:36:22 | 只看該作者
Sandra Horningzun?chst die Datenlage zu psychotherapeutischen und pharmakotherapeutischen Ans?tzen überblickartig dargestellt. Schlie?lich wird ein Therapieleitfaden zur Behandlung verschiedenster dissoziativer Symptome und St?rungen beschrieben. .Der modulare Aufbau des Leitfadens erlaubt es, das spezifische Vor
10#
發(fā)表于 2025-3-23 08:52:28 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-17 11:13
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
凌海市| 比如县| 神池县| 汉寿县| 宜阳县| 河西区| 泾阳县| 商河县| 金乡县| 潼南县| 铜梁县| 临漳县| 沧源| 临沭县| 恩平市| 三原县| 临城县| 长兴县| 井冈山市| 桑日县| 马关县| 屏东县| 遵义市| 资讯 | 乐都县| 永顺县| 汾西县| 那坡县| 天气| 岱山县| 息烽县| 昌平区| 胶南市| 涡阳县| 夏邑县| 拉萨市| 克什克腾旗| 开化县| 凤城市| 宕昌县| 民丰县|